Hims & Hers Health Appoints New Director, Amends Compensation
Ticker: HIMS · Form: 8-K/A · Filed: Jun 6, 2024 · CIK: 1773751
| Field | Detail |
|---|---|
| Company | Hims & Hers Health, Inc. (HIMS) |
| Form Type | 8-K/A |
| Filed Date | Jun 6, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, executive-compensation, amendment
Related Tickers: HIMS
TL;DR
Hims & Hers swapped a director and tweaked exec pay, filing an amendment on 4/24.
AI Summary
Hims & Hers Health, Inc. filed an 8-K/A on April 24, 2024, to amend a previous filing. The amendment concerns the departure of director Dr. Andrew Lee, effective April 24, 2024, and the appointment of Dr. Jessica Wu as a new director. The company also announced changes to its executive compensation arrangements.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can sometimes indicate underlying issues or strategic shifts that warrant closer investor scrutiny.
Key Players & Entities
- Hims & Hers Health, Inc. (company) — Registrant
- Dr. Andrew Lee (person) — Departing Director
- Dr. Jessica Wu (person) — Appointed Director
- April 24, 2024 (date) — Effective date of director departure and amendment filing
FAQ
Who is the departing director of Hims & Hers Health, Inc.?
Dr. Andrew Lee is the departing director.
When was the departure of Dr. Andrew Lee effective?
The departure of Dr. Andrew Lee was effective April 24, 2024.
Who has been appointed as a new director for Hims & Hers Health, Inc.?
Dr. Jessica Wu has been appointed as a new director.
What type of filing is this for Hims & Hers Health, Inc.?
This is a Form 8-K/A, an amendment to a previous filing.
What other items are addressed in this amendment besides director changes?
The amendment also addresses changes to compensatory arrangements of certain officers.
Filing Stats: 469 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-06-06 16:30:31
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value HIMS New York Stock Exchange
Filing Documents
- hims-20240424.htm (8-K/A) — 24KB
- 0001773751-24-000164.txt ( ) — 143KB
- hims-20240424.xsd (EX-101.SCH) — 2KB
- hims-20240424_lab.xml (EX-101.LAB) — 21KB
- hims-20240424_pre.xml (EX-101.PRE) — 12KB
- hims-20240424_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HIMS & HERS HEALTH, INC. Date: June 6, 2024 By: /s/ Andrew Dudum Andrew Dudum Chief Executive Officer